» Articles » PMID: 9788901

The Nature of Antioxidant Defense Mechanisms: a Lesson from Transgenic Studies

Overview
Date 1998 Oct 28
PMID 9788901
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen species (ROS) have been implicated in the pathogenesis of many clinical disorders such as adult respiratory distress syndrome, ischemia-reperfusion injury, atherosclerosis, neurodegenerative diseases, and cancer. Genetically engineered animal models have been used as a tool for understanding the function of various antioxidant enzymes in cellular defense mechanisms against various types of oxidant tissue injury. Transgenic mice overexpressing three isoforms of superoxide dismutase, catalase, and the cellular glutathione peroxidase (GSHPx-1) in various tissues show an increased tolerance to ischemia-reperfusion heart and brain injury, hyperoxia, cold-induced brain edema, adriamycin, and paraquat toxicity. These results have provided for the first time direct evidence demonstrating the importance of each of these antioxidant enzymes in protecting the animals against the injury resulting from these insults, as well as the effect of an enhanced level of antioxidant in ameliorating the oxidant tissue injury. To evaluate further the nature of these enzymes in antioxidant defense, gene knockout mice deficient in copper-zinc superoxide dismutase (CuZnSOD) and GSHPx-1 have also been generated in our laboratory. These mice developed normally and showed no marked pathologic changes under normal physiologic conditions. In addition, a deficiency in these genes had no effects on animal survival under hyperoxida. However, these knockout mice exhibited a pronounced susceptibility to paraquat toxicity and myocardial ischemia-reperfusion injury. Furthermore, female mice lacking CuZnSOD also displayed a marked increase in postimplantation embryonic lethality. These animals should provide a useful model for uncovering the identity of ROS that participate in the pathogenesis of various clinical disorders and for defining the role of each antioxidant enzyme in cellular defense against oxidant-mediated tissue injury.

Citing Articles

Testicular protective effects of hesperidin against chemical and biological toxicants.

Yan L, Wang J, Dai D, Zhang Y, Li Y, Xiao W Toxicol Res (Camb). 2024; 13(3):tfae078.

PMID: 38799410 PMC: 11116832. DOI: 10.1093/toxres/tfae078.


Vitamin C and its therapeutic potential in the management of COVID19.

Rs N, Reddy M, Batra S, Srivastava S, Syal K Clin Nutr ESPEN. 2022; 50:8-14.

PMID: 35871955 PMC: 9166267. DOI: 10.1016/j.clnesp.2022.05.026.


Hyperoxia and the cardiovascular system: experiences with hyperbaric oxygen therapy.

Schipke J, Muth T, Pepper C, Schneppendahl J, Hoffmanns M, Dreyer S Med Gas Res. 2022; 12(4):153-157.

PMID: 35435427 PMC: 9074980. DOI: 10.4103/2045-9912.337997.


A Cross-Sectional Study of Serum Glutathione Peroxidase: An Antioxidative Marker in Chronic Periodontitis and Chronic Kidney Disease.

Palathingal P, Mahendra J, Annamalai P, Varma S, Mahendra L, Thomas L Cureus. 2022; 14(2):e22016.

PMID: 35340502 PMC: 8913512. DOI: 10.7759/cureus.22016.


Toxicology of flavoring- and cannabis-containing e-liquids used in electronic delivery systems.

Stefaniak A, LeBouf R, Ranpara A, Leonard S Pharmacol Ther. 2021; 224:107838.

PMID: 33746051 PMC: 8251682. DOI: 10.1016/j.pharmthera.2021.107838.


References
1.
Frampton J, CONKIE D, Chambers I, McBain W, Dexter M, Harrison P . Changes in minor transcripts from the alpha 1 and beta maj globin and glutathione peroxidase genes during erythropoiesis. Nucleic Acids Res. 1987; 15(9):3671-88. PMC: 340775. DOI: 10.1093/nar/15.9.3671. View

2.
Takahashi K, Avissar N, Whitin J, Cohen H . Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys. 1987; 256(2):677-86. DOI: 10.1016/0003-9861(87)90624-2. View

3.
Cross C, Halliwell B, BORISH E, Pryor W, Ames B, Saul R . Oxygen radicals and human disease. Ann Intern Med. 1987; 107(4):526-45. DOI: 10.7326/0003-4819-107-4-526. View

4.
Epstein C, Avraham K, Lovett M, Smith S, Elroy-Stein O, Rotman G . Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci U S A. 1987; 84(22):8044-8. PMC: 299473. DOI: 10.1073/pnas.84.22.8044. View

5.
Avraham K, Schickler M, Sapoznikov D, Yarom R, Groner Y . Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase. Cell. 1988; 54(6):823-9. DOI: 10.1016/s0092-8674(88)91153-1. View